IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virax Biolabs Group LTD SHS New (VRAX)

CUSIP: G9495L109 | Healthcare · Biotechnology | Micro Cap | 20 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Farther Finance Advisors, LLC21
0.0% of portfolio›$4
StyleTurnoverLocationFiled
Farther Finance Advisors, LLC
21$40.0%IndexLowSan Francisco, CA2026-04-07